As the omicron variant threatens to wipe out monoclonal antibodies, a mainstay of COVID-19 treatment, Pfizer says its experimental antiviral pill sharply reduces hospitalizations and deaths among people at high risk of severe illness
The omicron variant of the coronavirus appears to cause less severe illness than earlier mutations but is more resistant to the two-dose Pfizer-BioNTech vaccine
The state is one of only seven without any laws governing virtual visits, meaning patients must deal with uneven insurance coverage and some medical providers who don’t want to bother.
Something went wrong. Please try again in a few minutes. If the problem persists, please contact customer service at 800-228-6397 or pgsupport@post-gazette.com.